PTEN acts downstream of the insulin receptor5; liver-specific PTEN deficiency promotes NAFLD and tumorigenesis while improving glucose tolerance [47]. The gene discussed is PTEN; the disease is metabolic dysfunction-associated steatotic liver disease.